CD274 and melanoma: Therefore, the latest literature data show a tendency towards a correlation between PD-L1 expression in melanoma samples and a positive response to PD-1-based immunotherapy, despite the difficulties related to the interpretation of immunocolorations and the heterogeneity of the expression of this biomarker.